Basaglar (insulin glargine) and Lantus (insulin glargine) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to: improve blood sugar levels in adults ...
PARIS, February 14 Sanofi-aventis announcedtoday that the Chicago Athenaeum Museum of Architecture and Design hasawarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposableinsulin ...
Sanofi, rival drugmakers Lilly, Boehringer settle suit allowing rival to Lantus insulin in US This product image provided by Sanofi shows Lantus SoloStar, the French drugmaker's once-daily insulin in ...
Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71 st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi ...
Sanofi has put off a biosimilar threat to Lantus till the end of 2016. In a patent settlement announced on Monday, the French drugmaker and U.S.-based Eli Lilly & Co. agreed to a royalty deal covering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback